课题基金 / 基金详情

Modulation of apoptosis by activation of protein kinasse G

Modulation of apoptosis by activation of protein kinasse G
通过激活蛋白激酶 G 调节细胞凋亡
批准号:
15590082
负责人:
MAEDA Sadaaki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MAEDA Sadaaki的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了低浓度一氧化氮(NO)对小鼠巨噬细胞RAW264中一氧化氮和过氧化氢诱导的细胞死亡的保护作用及其机制。高浓度(4 mM) SNP诱导RAW264细胞死亡。预处理100 μM SNP或1 mM二丁基- cgmp可减少线粒体中细胞色素c的释放,并可预防4 mM SNP诱导的RAW264细胞死亡。LY83583降低了SNP预处理的效果。二丁基- cgmp预处理对noc18、GSNO或SNP诱导的细胞死亡具有浓度依赖性。二丁基- cgmp预处理可抑制NO供体诱导的细胞色素c释放。KT5823(蛋白激酶G抑制剂)显著减弱SNP或二丁基cgmp的保护作用。这些结果表明,低浓度NO通过产生cGMP和激活pkg来保护RAW264细胞免受NO的细胞毒性,Bax从细胞质转移到线粒体,在细胞死亡中观察到更多的dridria。未经处理的RAW264细胞未显示Bax N-20抗体(pAb针对Bax的氨基酸11-30)相关免疫反应性。然而,一些细胞在4 mM SNP处理后显示Bax免疫染色的点状细胞质模式。细胞色素c免疫染色显示Bax阳性细胞呈弥漫性胞浆型。经4mm SNP处理后,Bax阳性细胞数量增加。100 μM SNP或1 mM二丁基- cgmp预处理均可抑制4 mM SNP诱导的Bax易位和Bax阳性细胞的增加。低浓度SNP或二丁基cgmp预处理可以阻止高浓度SNP诱导的p38 MAP激酶活化。这些结果表明,NO/cGMP信号通路通过抑制p38 MAP激酶的激活,抑制NO诱导的巨噬细胞凋亡,导致n端构象改变和Bax易位。低浓度SNP或1-羟基-2-氧-3,3-二-(2-氨基乙基)-1-三氮杂烯(no18)预处理24 h可降低h_2o_2诱导的细胞死亡、caspase-3活化和核断裂。可溶性鸟苷酸环化酶抑制剂LY83583和ODQ抑制了SNP和no18预处理的保护作用。蛋白激酶G抑制剂KT5823也显著降低了这些细胞保护作用。结果表明,低浓度NO通过产生cGMP和激活蛋白激酶G. Less来保护RAW264细胞免受h_2o_2诱导的凋亡
英文摘要
We investigated the protective effect of nitric oxide (NO) at a low concentration on NO- and hydrogen peroxide-induced cell death and its mechanism in mouse macrophage cell line, RAW264.SNP induced cell death in RAW264 cells at a high concentration (4 mM). Pretreatment with 100 μM SNP or 1 mM dibutylyl-cGMP reduced cytochrome c release from mitochondria and prevented the cell death induced by 4 mM SNP in RAW264 cells. The effect of SNP pretreatment was reduced by LY83583. Pretreatment with dibutylyl-cGMP prevented cell death induced by NOC 18, GSNO or SNP, in a concentration- dependent manner. Pretreatment with dibutylyl-cGMP prevented cytochrome c release induced by NO donors. The protective effect of SNP or dibutylyl-cGMP was significantly attenuated by KT5823 (a protein kinase G inhibitor). These results indicate that NO at a low concentration protects RAW264 cells from the cytotoxicity of NO through cGMP production and activation of PKG.Translocation of Bax from cytosol to mitochon … More dria was observed in the cell death. Untreated RAW264 cells displayed no Bax N-20 antibody (pAb raised against amino acids 11-30 of Bax)-associated immunoreactivity. However, some cells displayed a punctate cytosolic pattern of Bax immunostaining after 4 mM SNP treatment. Bax positive cells displayed a diffuse cytosolic pattern of cytochrome c immunostaining. The number of Bax positive cell was increased after 4 mM SNP treatment. Translocation of Bax and the increase of Bax positive cells induced by 4 mM SNP were inhibited by pretreatment with 100 μM SNP or 1 mM dibutylyl-cGMP. Activation of p38 MAP kinase induced by SNP at a high concentration was prevented by pretreatment with SNP at a low concentration or dibutylyl-cGMP. These results indicate that NO/cGMP signaling pathway inhibits NO-induced apoptpsis of macrophages by suppressing p38 MAP kinase activation, which results in N-terminal conformational change and translocation of Bax.Pretreatment with SNP or 1-hydroxy-2-oxo-3,3-bis-(2-aminoethyl)-1-triazene (NOC18), at a low concentration for 24 h reduced the H_2O_2-induced cell death, caspase-3 activation and nuclear fragmentation. LY83583 and ODQ, soluble guanylate cyclase inhibitors, inhibited the protective effect of both SNP and NOC18 pretreatment. Protein kinase G inhibitor KT5823 also significantly reduced these cytoprotective effects. These results indicate that NO at a low concentration protects RAW264 cells from H_2O_2-induced apoptosis though cGMP production and activation of protein kinase G. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research on the apelin as a therapeutic target molecule in ischemic retinopathy using genetically modified animals
  • 批准号:
    24590131
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.49万
  • 财政年份:
    2012
  • 负责人:
    MAEDA Sadaaki
  • 依托单位:
Research on the onset and progression of amyotrophic lateral sclerosis using genetically modified animals
  • 批准号:
    21590110
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2009
  • 负责人:
    MAEDA Sadaaki
  • 依托单位:
Dual effect of nitric oxide on cell death : Induction and protection of apoptosis
  • 批准号:
    13672314
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $0.45万
  • 财政年份:
    2001
  • 负责人:
    MAEDA Sadaaki
  • 依托单位:
Effects of nitric oxide on pain perception by primary afferent neurons in inflammation
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: